Beijing Engineering Research Center for BioNanotechnology and CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for NanoScience and Technology, No. 11 Zhongguancun Beiyitiao, Beijing, 100190, P. R. China.
The University of Chinese Academy of Sciences, 19 A Yuquan Road, Shijingshan District, Beijing, 100049, P. R. China.
Adv Healthc Mater. 2017 Aug;6(15). doi: 10.1002/adhm.201601403. Epub 2017 Mar 21.
Conventional immunoassays suffer from at least one of these following limitations: long processing time, high costs, poor user-friendliness, technical complexity, poor sensitivity and specificity. Microfluidics, a technology characterized by the engineered manipulation of fluids in channels with characteristic lengthscale of tens of micrometers, has shown considerable promise for improving immunoassays that could overcome these limitations in medical diagnostics and biology research. The combination of microfluidics and immunoassay can detect biomarkers with faster assay time, reduced volumes of reagents, lower power requirements, and higher levels of integration and automation compared to traditional approaches. This review focuses on the materials-related aspects of the recent advances in microfluidics-based immunoassays for point-of-care (POC) diagnostics of biomarkers. We compare the materials for microfluidic chips fabrication in five aspects: fabrication, integration, function, modification and cost, and describe their advantages and drawbacks. In addition, we review materials for modifying antibodies to improve the performance of the reaction of immunoassay. We also review the state of the art in microfluidic immunoassays POC platforms, from the laboratory to routine clinical practice, and also commercial products in the market. Finally, we discuss the current challenges and future developments in microfluidic immunoassays.
处理时间长、成本高、用户友好性差、技术复杂、灵敏度和特异性差。微流控技术的特点是在具有数十微米特征长度尺度的通道中对流体进行工程化操作,它在改善免疫分析方面显示出了巨大的潜力,可以克服医学诊断和生物学研究中的这些限制。与传统方法相比,微流控技术与免疫分析的结合可以实现更快的检测时间、更少的试剂体积、更低的功率要求以及更高水平的集成和自动化,从而检测生物标志物。本综述重点介绍了基于微流控的免疫分析在即时诊断(POC)生物标志物检测方面的最新进展中的与材料相关的方面。我们从五个方面比较了微流控芯片制造的材料:制造、集成、功能、修饰和成本,并描述了它们的优缺点。此外,我们还综述了修饰抗体以改善免疫分析反应性能的材料。我们还回顾了从实验室到常规临床实践的微流控免疫分析 POC 平台的最新进展,以及市场上的商业产品。最后,我们讨论了微流控免疫分析当前的挑战和未来的发展。